ScreenerHero
CLBIOCorline Biomedical AB
STO · SE · Healthcare · Biotechnology · corline.se
18.15SEK+0.83%Mkt Cap: 45.37M $P/E: —

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden. The company's products are based on C…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap45.37M $
Enterprise Value42.35M $
Revenue (TTM)1.02M $
Gross Profit595.53K $
Net Income (TTM)-1.41M $
Revenue/Share0.0407 USD
Last Price18.15 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)20.34
PEG—
EV/EBITDA-31.37
EV/Revenue41.51
P/S44.35
P/B4.71
EPS (TTM)-0.56
EPS (Forward)0.89
52W Range
11.2543% of range27.20
52W High27.20 SEK
52W Low11.25 SEK
Profitability
Gross Margin81.37%
Oper. Margin-58.16%
EBITDA Margin-132.33%
Profit Margin-192.31%
ROE-15.69%
ROA-14.93%
Growth
Revenue Growth93.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.69M $
CapEx (TTM)94.03K $
FCF Margin-175.35%
FCF Yield-3.94%
Net Debt-2.64M $
Net Debt/EBITDA1.96
Balance Sheet
Debt/Equity5.23
Current Ratio6.41
Quick Ratio6.13
Book Value/Sh3.844 SEK
Cash/Share1.259 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)29.00 SEK
Upside (mean)+59.8%
Target Range29.00 SEK – 29.00 SEK
# Analysts1
Ownership
Shares Out.26.13M
Float11.30M
Insiders62.42%
Institutions12.84%
Technical
SMA 5017.77 (+2.2%)
SMA 20017.12 (+6.0%)
Beta0.30
S&P 52W Chg18.16%
Avg Vol (30d)4.02K
Avg Vol (10d)5.68K
Technical Indicators
RSI (14)52.8
MACD0.0896
MACD Signal0.0549
MACD Hist.+0.0347
BB Upper18.45 SEK
BB Middle17.74 SEK
BB Lower17.03 SEK
BB Width8.00%
ATR (14)0.6138 SEK
Vol Ratio (20d)1.10x